|
|
|
|
|
|
| Case Report | |
|
|
|
|
Title |
|
|
Aiesha Ahmeda, b, Max R Lowdena
aPenn State College of
Medicine, Hershey Medical Center, Department
of Neurology - EC037, 30 Hope Drive, Hershey, PA 17033, USA Manuscript accepted for publication April 7, 2009 Short title: Myoadenylate Deaminase Deficiency |
|
| Abstract | |
|
Key words: Myoadenylate deaminase deficiency; Myalgia; Pain |
|
| Introduction | |
|
|
|
|
Case report |
|
|
The patient had a past medical history of spontaneous pneumothoraces and hypercholesterolemia. Family history reveals no neuromuscular diseases. Interventions including physical therapy, aquatherapy, tizanidine, tricyclic antidepressants, and nonsteroidal anti-inflammatory drugs provided minimal relief. On physical examination, he had intact muscle bulk, strength and tone throughout. His muscle stretch reflexes were normal. The remainder of the neurological examination was normal. Evaluations including blood work for connective tissue disorders, chemistry, thyroid studies, creatine phosphokinase and electrodiagnostic studies which failed to identify an etiology for his complaints. A muscle biopsy of the left vastus lateralis was performed in light of persistent symptomatology. It showed mild morphologic abnormalities consistent with variation in myofiber size and shape (Fig. 1). Myofiber glycogen content and staining for phosphorylase, phosphofructokinase, and acid phosphatase were unrevealing. Staining for myoadenylate deaminase activity was markedly diminished (Fig. 2). Biochemical analyses for acid maltase, fatty acid transport (carnitine, carnitine palmitoyltransferase) and mitochondrial enzymes including respiratory chain enzymes were unremarkable.
Figure 1. Hematoxylin and eosin stain of muscle showing mild variation in myofiber size and shape but overall preservation of normal morphology as typically seen in myoadenylate deaminase deficiency. x 400.
Figure 2. Adenosine monophosphate deaminase stain of muscle showing normal control (a) and markedly diminished myoadenylate deaminase activity (b). x 400. |
|
| Discussion | |
|
|
|
| Footnotes | |
|
|
|
| References | |
|
|
|
| 1. |
Riggs JE, Schochet SS,
Jr., Webb RW. Exertional myalgia syndrome associated with diminished
serum ammonia elevation in ischemic exercise testing. Mil Med
1999;164:663-665. Medline | CrossRef |
| 2. |
Shumate JB, Katnik R,
Ruiz M, Kaiser K, Frieden C, Brooke MH, Carroll JE. Myoadenylate
deaminase deficiency. Muscle Nerve 1979;2:213-216. Medline | CrossRef |
| 3. |
Marin R, Connick E.
Tension myalgia versus myoadenylate deaminase deficiency: a case report.
Arch Phys Med Rehabil 1997;78:95-97.
Medline | CrossRef |
| 4. |
Hayes DJ, Summers BA,
Morgan-Hughes JA. Myoadenylate deaminase deficiency or not? Observations
on two brothers with exercise-induced muscle pain. J Neurol Sci
1982;53:125-136. Medline | CrossRef |
| 5. |
Kelemen J, Rice DR,
Bradley WG, Munsat TL, DiMauro S, Hogan EL. Familial myoadenylate
deaminase deficiency and exertional myalgia. Neurology 1982;32:857-863.
Medline | CrossRef |
| 6. |
Rossi LN, Cornelio F,
Dworzak F, Morandi L, Rossi G, Di Mauro S. Myoadenylate deaminase
deficiency in a 5-year-old boy with intermittent muscle pain. Helv
Paediatr Acta 1984;39:89-93. Medline | CrossRef |
| 7. |
Sinkeler SP, Wevers
RA, Joosten EM, Binkhorst RA, Oei LT, Van't Hof MA, De Haan AF.
Improvement of screening in exertional myalgia with a standardized
ischemic forearm test. Muscle Nerve 1986;9:731-737. Medline | CrossRef |
| 8. |
Lally EV, Friedman JH,
Kaplan SR. Progressive myalgias and polyarthralgias in a patient with
myoadenylate deaminase deficiency. Arthritis Rheum 1985;28:1298-1302. |
Digital Object Identifier (DOI):10.4021/jocmr2009.04.1231
About
DOI and
CrossRef
Journal of Clinical Medicine Research is a member of CrossRef.